By proceeding, you agree to our Terms of Use and Privacy Policy.
Touchlight AAV is advancing gene therapy by offering, dbDNA, its synthetic, linear, double stranded DNA as the new industry standard for transfection-based AAV production.
29-01 April 2022
Welcome to the 2nd Annual Gene Therapy Comparability Summit One of the biggest hurdles in obtaining market authorization for gene therapies is the ability to effectively demonstrate comparability when changes are made during development.
Event Ended
USA
Paid
Boston